Molecular Insights into Cardiomyopathies Associated with Desmin (DES) Mutations

Overview

Journal Biophys Rev

Publisher Springer

Specialty Biophysics

Date 2018 Jun 22

PMID 29926427

Citations 71

Authors

Andreas Brodehl

Anna Gaertner-Rommel

Hendrik Milting

Affiliations

Soon will be listed here.

Abstract

Increasing usage of next-generation sequencing techniques pushed during the last decade cardiogenetic diagnostics leading to the identification of a huge number of genetic variants in about 170 genes associated with cardiomyopathies, channelopathies, or syndromes with cardiac involvement. Because of the biochemical and cellular complexity, it is challenging to understand the clinical meaning or even the relevant pathomechanisms of the majority of genetic sequence variants. However, detailed knowledge about the associated molecular pathomechanism is essential for the development of efficient therapeutic strategies in future and genetic counseling. Mutations in DES, encoding the muscle-specific intermediate filament protein desmin, have been identified in different kinds of cardiac and skeletal myopathies. Here, we review the functions of desmin in health and disease with a focus on cardiomyopathies. In addition, we will summarize the genetic and clinical literature about DES mutations and will explain relevant cell and animal models. Moreover, we discuss upcoming perspectives and consequences of novel experimental approaches like genome editing technology, which might open a novel research field contributing to the development of efficient and mutation-specific treatment options.

Citing Articles

Genetic and Epigenetic Intersections in COVID-19-Associated Cardiovascular Disease: Emerging Insights and Future Directions.

Sabit H, Arneth B, Altrawy A, Ghazy A, Abdelazeem R, Adel A Biomedicines. 2025; 13(2).

PMID: 40002898 PMC: 11852909. DOI: 10.3390/biomedicines13020485.

Functional impact of the head domain variants of (Desmin) on filament assembly.

Voss S, Walhorn V, Holler S, Gartner A, Pohl G, Tiesmeier J Genes Dis. 2024; 12(1):101238.

PMID: 39650696 PMC: 11620975. DOI: 10.1016/j.gendis.2024.101238.

Geng L, Wang M, Wang K, Xu L, Li J, Liu F J Int Med Res. 2024; 52(11):3000605241291741.

PMID: 39501717 PMC: 11539263. DOI: 10.1177/03000605241291741.

Natural History, Phenotype Spectrum and Clinical Outcomes of Desmin ()-Associated Cardiomyopathy.

Asatryan B, Rieder M, Murray B, Muller S, Tichnell C, Gasperetti A medRxiv. 2024; .

PMID: 39252922 PMC: 11383507. DOI: 10.1101/2024.08.24.24311904.

In Vivo Approaches to Understand Arrhythmogenic Cardiomyopathy: Perspectives on Animal Models.

Risato G, Branas Casas R, Cason M, Bueno Marinas M, Pinci S, De Gaspari M Cells. 2024; 13(15).

PMID: 39120296 PMC: 11311808. DOI: 10.3390/cells13151264.

References

Golbus J, Puckelwartz M, Dellefave-Castillo L, Fahrenbach J, Nelakuditi V, Pesce L . Targeted analysis of whole genome sequence data to diagnose genetic cardiomyopathy. Circ Cardiovasc Genet. 2014; 7(6):751-759. PMC: 4270910. DOI: 10.1161/CIRCGENETICS.113.000578. View

Coulombe P . The Molecular Revolution in Cutaneous Biology: Keratin Genes and their Associated Disease: Diversity, Opportunities, and Challenges. J Invest Dermatol. 2017; 137(5):e67-e71. PMC: 5509967. DOI: 10.1016/j.jid.2016.04.039. View

Brodehl A, Gaertner-Rommel A, Klauke B, Grewe S, Schirmer I, Peterschroder A . The novel αB-crystallin (CRYAB) mutation p.D109G causes restrictive cardiomyopathy. Hum Mutat. 2017; 38(8):947-952. DOI: 10.1002/humu.23248. View

Nouhravesh N, Ahlberg G, Ghouse J, Andreasen C, Svendsen J, Haunso S . Analyses of more than 60,000 exomes questions the role of numerous genes previously associated with dilated cardiomyopathy. Mol Genet Genomic Med. 2016; 4(6):617-623. PMC: 5118206. DOI: 10.1002/mgg3.245. View

Dagvadorj A, Olive M, Urtizberea J, Halle M, Shatunov A, Bonnemann C . A series of West European patients with severe cardiac and skeletal myopathy associated with a de novo R406W mutation in desmin. J Neurol. 2004; 251(2):143-9. DOI: 10.1007/s00415-004-0289-3. View

Kaminska A, Strelkov S, Goudeau B, Olive M, Dagvadorj A, Fidzianska A . Small deletions disturb desmin architecture leading to breakdown of muscle cells and development of skeletal or cardioskeletal myopathy. Hum Genet. 2003; 114(3):306-13. DOI: 10.1007/s00439-003-1057-7. View

Bauce B, Basso C, Rampazzo A, Beffagna G, Daliento L, Frigo G . Clinical profile of four families with arrhythmogenic right ventricular cardiomyopathy caused by dominant desmoplakin mutations. Eur Heart J. 2005; 26(16):1666-75. DOI: 10.1093/eurheartj/ehi341. View

Maron B, Towbin J, Thiene G, Antzelevitch C, Corrado D, Arnett D . Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and.... Circulation. 2006; 113(14):1807-16. DOI: 10.1161/CIRCULATIONAHA.106.174287. View

Shanks G, Tester D, Nishtala S, Evans J, Ackerman M . Genomic Triangulation and Coverage Analysis in Whole-Exome Sequencing-Based Molecular Autopsies. Circ Cardiovasc Genet. 2017; 10(5). DOI: 10.1161/CIRCGENETICS.117.001828. View

10.

Herrmann H, Haner M, Brettel M, Muller S, Goldie K, Fedtke B . Structure and assembly properties of the intermediate filament protein vimentin: the role of its head, rod and tail domains. J Mol Biol. 1996; 264(5):933-53. DOI: 10.1006/jmbi.1996.0688. View

11.

Brodehl A, Dieding M, Biere N, Unger A, Klauke B, Walhorn V . Functional characterization of the novel DES mutation p.L136P associated with dilated cardiomyopathy reveals a dominant filament assembly defect. J Mol Cell Cardiol. 2016; 91:207-14. DOI: 10.1016/j.yjmcc.2015.12.015. View

12.

Brayson D, Shanahan C . Current insights into LMNA cardiomyopathies: Existing models and missing LINCs. Nucleus. 2017; 8(1):17-33. PMC: 5287098. DOI: 10.1080/19491034.2016.1260798. View

13.

Dunand M, Lobrinus J, Jeannet P, Behin A, Claeys K, Selcen D . Confirmation that abnormal desmin accumulation and migration are due to a desmin gene mutation in a familial cardiomyopathy and distal myopathy. Neuromuscul Disord. 2009; 19(11):802. DOI: 10.1016/j.nmd.2009.07.013. View

14.

Gehmlich K, Lambiase P, Asimaki A, Ciaccio E, Ehler E, Syrris P . A novel desmocollin-2 mutation reveals insights into the molecular link between desmosomes and gap junctions. Heart Rhythm. 2011; 8(5):711-8. PMC: 3085091. DOI: 10.1016/j.hrthm.2011.01.010. View

15.

Vattemi G, Neri M, Piffer S, Vicart P, Gualandi F, Marini M . Clinical, morphological and genetic studies in a cohort of 21 patients with myofibrillar myopathy. Acta Myol. 2011; 30(2):121-6. PMC: 3235861. View

16.

Joanne P, Chourbagi O, Hourde C, Ferry A, Butler-Browne G, Vicart P . Viral-mediated expression of desmin mutants to create mouse models of myofibrillar myopathy. Skelet Muscle. 2013; 3(1):4. PMC: 3599656. DOI: 10.1186/2044-5040-3-4. View

17.

Geisler N, Kaufmann E, Weber K . Antiparallel orientation of the two double-stranded coiled-coils in the tetrameric protofilament unit of intermediate filaments. J Mol Biol. 1985; 182(1):173-7. DOI: 10.1016/0022-2836(85)90035-x. View

18.

Herrmann H, Aebi U . Intermediate filaments: molecular structure, assembly mechanism, and integration into functionally distinct intracellular Scaffolds. Annu Rev Biochem. 2004; 73:749-89. DOI: 10.1146/annurev.biochem.73.011303.073823. View

19.

Liu J, Tang M, Mestril R, Wang X . Aberrant protein aggregation is essential for a mutant desmin to impair the proteolytic function of the ubiquitin-proteasome system in cardiomyocytes. J Mol Cell Cardiol. 2006; 40(4):451-4. DOI: 10.1016/j.yjmcc.2005.12.011. View

20.

Heckmann M, Bauer R, Jungmann A, Winter L, Rapti K, Strucksberg K . AAV9-mediated gene transfer of desmin ameliorates cardiomyopathy in desmin-deficient mice. Gene Ther. 2016; 23(8-9):673-9. PMC: 4976287. DOI: 10.1038/gt.2016.40. View